Vaping found to negatively impact women’s fertility, new study reveals

A recent study conducted by Hertility, a women’s health firm, discovered that vaping can negatively affect women’s fertility. During the study, researchers analyzed the blood samples of 8,340 women and found reduced levels of anti-Müllerian hormone (AMH), an indicator of ovarian egg reserve, in smokers and vapers compared to non-smokers. Dr. Helen O’Neill, a participating researcher from UCL, emphasized the importance of quitting smoking and vaping, especially for women trying to conceive.

Despite the warnings, the study revealed that 20% of British women attempting to get pregnant continue to vape, exposing the prevalent usage of such nicotine products during critical reproductive periods. Alongside vaping, the study also highlighted frequent alcohol consumption and recreational drug use among women trying to conceive, which could similarly compromise fertility.

Parallel to concerns about the effects of vaping on fertility, the tobacco industry is experiencing controversies over new nicotine products such as Zyn, a nicotine pouch manufactured by Philip Morris. The product, primarily targeted at adult smokers, has stirred debates over its appeal to underage users and its efficacy as a smoking cessation aid. Although considered less harmful than cigarettes, regulators and health experts are cautious about the risks these nicotine pouches pose to youth and their actual benefits in helping smokers quit.

Current research and regulatory scrutiny over products like Zyn and the impacts of vaping underscore the ongoing efforts to better understand and mitigate the health risks associated with new forms of nicotine consumption. As the scientific community continues to explore these topics, the findings serve to inform individuals, especially women of childbearing age and the youth, about the potential health implications entailed.